Benitec Biopharma Inc.

BNTCCIK 0001808898 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Mar 20, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0131

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 29, 20265.02 · Departure/Election May 14, 2026no items parsed Feb 12, 2026no items parsed Dec 2, 2025no items parsed Nov 14, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Benitec Biopharma Inc.

Name	Roles	Filings
Mehta Kishan	Director	2
Friedman David Matthew	Director	1
Mukadam Sophie	Officer	1

Showing 11-13 of 13

Per pagePrevPage 3 of 3

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Benitec Biopharma Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Averill Madison Master Fund, Ltd.	30	47%	+0.6%	0.0%	+27.6%	-25.4%
2	Averill Master Fund, Ltd.	30	47%	+0.6%	0.0%	+27.6%	-25.4%
3	Cowen Aaron	30	47%	+0.6%	0.0%	+27.6%	-25.4%
4	Suvretta Capital Management, LLC	30	47%	+0.6%	0.0%	+27.6%	-25.4%

All filings

37 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Nov 20, 2025	Banks Jerel A. Chief Executive Officer · Director	Holdings only	-	-	-
Nov 20, 2025	Mukadam Sophie Chief Operating Officer	Holdings only	-	-	-
Nov 10, 2025	Suvretta Capital Management, LLC Director · 10% Owner	PPurchase	751,111	$13.50	$10,139,999
Nov 7, 2025	Mates Sharon Director	Holdings only	-	-	-
Apr 2, 2025	Suvretta Capital Management, LLC Director · 10% Owner	PPurchase	9,503	$12.63	$120,023

Showing 11-15 of 37

Per pagePrevPage 3 of 8Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value